We analysed serotype-specific antigens of human rotavirus (HRV) by the use of neutralizing monoclonal antibodies (N-MAbs). The reactivity patterns of 12 serotypespecific N-MAbs against 15 HRV strains in a neutralization test revealed great intraserotypic antigenic variation especially those belonging to serotypes 2, 3 and 4. On the basis of the protein specificity of the antibodies examined, it was suggested that whereas serotype 2-specific neutralization epitopes were present on both VP3 and VP7 outer capsid proteins, serotype 1-, 3-and 4-specific neutralization epitopes were located on VP7. Serotype-specific neutralization epitopes on VP7 of the serotype 1 HRV KU strain were analysed further using mutants of the KU strain resistant to different serotype l-specific N-MAbs. The result suggested the presence of at least five operationally overlapping neutralization epitopes on VP7 of the KU strain, which collectively constituted a single large neutralization domain.
. The analysis of cross-reactive neutralization epitopes on VP3 protein using these cross-reactive N-MAbs has already been reported by Taniguchi et al. (1978a) . The characters of selected serotype-specific N-MAbs were also reported elsewhere (Taniguchi et al., 1985; 1987b) .
The present study describes the protein specificity of 12 serotype-specific N-MAbs, their reactivity in neutralization tests and operational mapping of the serotype-specific neutralization epitopes on the VP7 protein of the serotype 1 KU strain as analysed using antigenic variants isolated by selection for resistance to serotype 1-specific N-MAbs. Fifteen well-characterized HRV strains were used in this study: (i) KU, K8, S12 and Wa (serotype 1), (ii) $2, AK-26, P1, DS-1 and HN-126 (serotype 2), (iii) YO, $3, P2 and AK-35 (serotype 3) and (iv) Hochi and ST-3 (serotype 4). Two animal rotaviruses, simian rotavirus (SA11 ; serotype 3) and bovine rotavirus (NCDV; serotype 6) were used as reference strains. In addition, two reassortant viruses of strains C15 (Urasawa et al., 1986) and C148 (unpublished observations) were used to determine the protein specificity of N-MAbs. All viruses were pretreated with 10 ~tg/ml of acetylated trypsin (type V-S from bovine pancreas; Sigma) and were propagated in MA-104 cells in the presence of trypsin (1 p.g/ml).
As shown in Table 1 , five N-MAbs prepared against serotype 1 KU specifically neutralized the infectivity of all serotype 1 strains examined. Of these antibodies, KU-4 and KU-6All showed a high neutralizing activity (titre, >/1 : 25 600). Of the four monoclonal antibodies raised against the serotype 2 $2 strain, $2-2G10 and $2-4E9 neutralized all strains belonging to serotype 2, whereas $2-2H11 and $2-3E12 showed little or no neutralizing activity to the AK-26, DS-1 or HN-126 strains despite their strong reactivity with $2 and P1. YO-1E2 and YO-1G4 antibodies raised against serotype 3 YO strain strongly neutralized YO, $3, P2 and SA 11 strains of serotype 3 but not AK-35, an antigenic variant of serotype 3 isolated in Kenya (Urasawa et al., 1987) . ST-2G7 antibody prepared against serotype 4 ST-3 neutralized both the ST-3 and Hochi strains; however, there was a more than 16-fold difference between the neutralizing titres against the two strains.
The protein specificity of these serotype-specific N-MAbs was examined using gene reassortants since repeated immunoprecipitation tests (Taniguchi et al., 1985 (Taniguchi et al., , 1987b failed to determine the specificity. The reassortant C15 used in this study was obtained from a coinfection of serotype 1 (Wa) and serotype 2 (HN-126) strains and had two distinct serotypespecific antigens: a serotype 1-specific antigen on VP3 encoded by RNA segment 4 from the Wa parent and a serotype 2-specific antigen on VP7 encoded by RNA segment 8 or 9 from the HN-126 parent (Urasawa et al., 1986; Taniguchi et al., 1987b) . The reassortant C148, in contrast, was derived from a co-infection of serotype 3 (YO) and serotype 4 (Hochi) strains and had serotype 4-specific VP3 encoded by RNA segment 4 of the Hochi parent and serotype 3-specific VP7 encoded by RNA segment 8 or 9 of the YO parent (unpublished observations; Taniguchi et al., 1987 b) (for the gene segment derivation of this reassortant, see Table 2 ). As shown in Table  2 , five serotype 1-specific N-MAbs reacted with Wa but not with C15 having serotype 1-specific VP3, indicating that all these antibodies are probably directed against VP7. Serotype 2-specific N-MAb $2-2G 10 neutralized both HN-126 and C 15 having serotype 2-specific VP7, suggesting that $2-2G10 is also directed against VP7. Another serotype 2-specific N-MAb $2-4E9 neutralized the HN-126 parent but not C15 with serotype 2-specific VP7 and therefore was assumed to be directed against VP3. The protein specificity of the remaining two serotype 2-specific N-MAbs, $2-2H11 and $2-3E12, could not be determined, because they did not react with the HN-126 strain, a parent of C15. Serotype 3-specific antibody YO-1E2 and YO-1G4 neutralized both the YO parent and C148 with serotype 3-specific VP7, whereas serotype 4-specific antibody ST-2G7 neutralized the Hochi parent but not C148 with serotype 4-specific VP3. These results indicated that YO-1E2, YO-1 G4 and ST-2G7 antibodies were all probably directed against VP7. The plausibility of this result was corroborated by the complete concordance with the protein assignment of monoclonal antibodies, KU-4 (serotype 1-specific), $2-2G10 and $2-4E9 (serotype 2-specific), YO-1E2 (serotype 3-specific) and ST-2G7 (serotype 4-specific) determined by either a haemagglutination inhibition test with single HRV gene~ubstitution reassortants of rhesus rotavirus (Taniguchi et al., 1987b) 
Reactivity patterns of serotype-specific N-MAbs against rotaviruses as determined by neutralization tests
Neutralizing titre t The isotypes of the immunoglobulins were determined by Ouchterlony's double-immunodiffusion test using rabbit antisera to mouse IgG, IgM, IgGl, IgG2a, Rehovot, Israel) . These N-MAbs were partly characterized previously (Taniguchi et al., 1987a, b t Strain C15 has serotype 1 (Wa)-specific antigen on VP3 and serotype 2 (HN-126)-specific antigen on VP7 (Urasawa et al., 1986) .
:~ Strain C 148 possessed Hochi RNA segments, 1, 2, 3, 4 (encoding VP3), 5, 6 and 10. Though the assignment of segments 8 and 9 could not be determined by genotype analysis, the YO origin of VP7 of the reassortant was confirmed by its preferential reactivity with serotype 3-specific polyclonal and monoclonal antibodies (unpublished observations; Taniguchi et al., 1987b) . § Neutralizing titre of < 100. I] Protein specificity of these N-MAbs was reported previously (Taniguchi et al., 1985 (Taniguchi et al., , 1987b . ¶ Protein specificity could not be determined. Table 3 . tests with radiolabelled HRV polypeptides (Taniguchi et al., 1985) . Apart from the results obtained here, our previous study (Taniguchi et al., 1985) had already demonstrated that three other serotype 2-specific N-MAbs, $2-2F2, $2-2F3 and $2-3H8, immunoprecipitated VP3 protein.
Short communication 455

Epitope analysis of antigenic variants (KU strain) selected with serotype 1-specific N-MAbs as determined by the neutralization test
Next, in order to analyse further serotype-specific neutralization epitopes on VP7 protein, antigenic variants were isolated by growing serotype 1 strain KU in the presence of anti-VP7 serotype 1-specific N-MAbs. Antigenic variants of KU were selected and isolated as follows. The parental KU strain was plaque-purified twice in an MA-104 cell monolayer. Fifty ~tl of serial 10-fold dilutions of the KU strain pretreated with trypsin (10 ~tg/ml) were mixed with equal volumes of ascitic fluid diluted 1 : 100 or 1 : 500 in Eagle's minimal essential medium. After 1 h incubation at 37 °C, 0.1ml of the virus-antibody mixture was inoculated onto an MA-104 cell monolayer formed in test tubes. After 1 h adsorption, the cells were washed with phosphatebuffered saline and fed with 1 ml of a maintenance medium containing ascitic fluid diluted 1 : 500 or 1 : 2000 and trypsin (5 ~tg/ml). The infected cells were incubated in a roller tube culture apparatus and were harvested after 5 to 7 days. Growth of the virus was examined by an ELISA using group A rotavirus-specific YO-156 antibody (Taniguchi et al., 1984) , and its resistance to the corresponding N-MAb was confirmed by the fluorescent focus neutralization test. After an additional cycle of virus neutralization and multiplication, the resultant antigenic variants were plaque-purified at least twice in CV-1 cell monolayers. Each variant was designated by the capital letter 'V' followed by the name of the monoclonal antibody used for its selection.
We obtained four antigenic variants (V-KU-3C7, V-KU-4, V-KU-5H1 and V-KU-6A11) of the KU strain except for a variant resistant to KU-2 antibody. Table 3 shows the result of the cross-neutralization test between the four variants of the KU strain and the five serotype 1-specific N-MAbs. V-KU-3C7 was shown to have acquired resistance not only to the KU-3C7 antibody used for its selection but also to KU-2, KU-5H1 and KU-6A11 antibodies. This result suggests that the neutralization epitope recognized by the KU-3C7 antibody (KU-3C7 epitope) operationally overlaps those recognized by antibodies KU-2, KU-5H1 and KU-6A11 (KU-2, KU-5H1 and KU-6A11 epitopes). Similar overlapping was suggested between the KU-4 and KU-6A11 epitopes, and between the KU-6A11 epitope and the KU-3C7, KU-4 and KU-5H1 epitopes (Table 3) . Thus, it was found that the five serotype 1-specific neutralization epitopes on KU strain VP7 recognizable by five different N-MAbs operationally (or functionally) overlap one another and collectively constitute a single large neutralization domain, as shown in Fig. 1 .
Previous studies using polyclonal antibodies (Wyatt et al., 1983; Urasawa et al., 1984) suggested the presence of considerable antigenic variation among strains belonging to the individual serotypes of HRV. The present study using serotype-specific N-MAbs confirmed intraserotypic antigenic variation in HRV, especially in serotypes 2, 3 and 4.
It has already been established that the major antigenic sites determining serotype 1, 2, 3 and 4 specificity of HRV reside on glycoprotein VP7 Shaw et al., 1986; Taniguchi et al., 1987b) , although a few cross-reactive neutralization epitopes have been reported to be present on the same protein (Sabara et al., 1985; Coulson et al., 1986) . On the other hand, recent studies on strain M37, an isolate having serotype 4-specific VP3 and serotype 1-specific VP7 (Hoshino et al., 1985) , as well as on a gene reassortant prepared in vitro having serotype 1-specific VP3 and serotype 2-specific VP7 (Urasawa et al., 1986 ) strongly suggest that VP3, in addition to VP7, carries a neutralizing antigen defining the individual serotype specificity. However, our results from serotype-specific N-MAbs obtained up to now have confirmed the presence of only serotype 2-specific neutralization epitopes on VP3 (Table 2; Taniguchi et al., 1985) . The question of whether or not there are serotype 1-, 3-and 4-specific neutralization epitopes on VP3 will be answered by the outcome of experiments to prepare VP3-directed serotype-specific N-MAbs.
The usefulness of antigenic variants resistant to MAbs for analysis of neutralization epitopes has been demonstrated for influenza virus (Lubeck & Gerhard, 1981) , poliovirus (Minor et al., 1983) and other viruses (Wiktor & Koprowski, 1980; Yewdell & Gerhard, 1981) . Recently, the antigenic site on the major outer capsid glycoprotein VP7 of simian rotavirus SA11 has been analysed using antigenic variants resistant to N-MAbs as well as by a competitive binding assay with a number of MAbs (Sonza et al., 1984; Lazdins et al., 1985; Dyall-Smith et al., 1986) . Shaw et al. (l 986) investigated the functional topography of neutralization epitopes on the VP7 as well as the VP3 outer capsid proteins of rhesus rotavirus using similar techniques and identified two distinct neutralization domains on VP7. On the basis of RNA sequence analysis of the VP7 glycoprotein gene obtained from mutant viruses resistant to N-MAbs, Dyall-Smith et al. (1986) identified three regions related to neutralization epitopes, A (amino acids 87 to 96), B (amino acids 145 to 150) and C (amino acids 211 to 213). Of these, region C was considered to be an immunodominant neutralization site, since antigenic variants resistant to the N-MAbs directed at this region showed a 10-fold increase in resistance to neutralization by hyperimmune (polyclonal) antiserum. Their results further indicated that although widely spaced in the linear molecule, the two regions, A and C, are likely to be in close proximity to form one antigenic site in the three-dimensional folding of the native protein. In the present study, neutralization epitopes on the VP7 protein of serotype 1 HRV KU strain were analysed using variant KU strains resistant to N-MAbs, and at least five operationally overlapping neutralization epitopes collectively constituting a single large neutralization domain are delineated. Competition binding experiments will be required to elucidate the structural relationship between the five neutralization epitopes. Considering the results of Shaw et al. (1986) and Dyall-Smith et al. (1986) mentioned above, however, the possible presence of a second distinct neutralization domain on the VP7 of KU strain requires further study. Sequencing of the VP7 protein genes obtained from these N-MAb-resistant mutants, together with a search for an immunodominant neutralization site, are now being carried out. This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan.
